Question Everything. See who's reporting it.

Gilead signs generic deals for experimental Ebola drug

Source: The Hindu

The story in brief

Gilead Sciences signed royalty-free deals with three generic drugmakers to make its experimental Ebola prevention drug available in 127 low- and lower-middle-income countries. The drug, obeldesivir, is in trials and not yet approved for any use. Manufacturing is set to begin ahead of trial results and regulatory filings.

NEWXFree on Android and iPhone. Open in NEWX